Prevention of therapeutically induced regression of sarcoma 180 by immunologic enhancement.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000276:immunology; D005260:Female; D007106:Immune Sera / Q000494:pharmacology; D007114:Immunization; D008099:Liver / Q000276:immunology; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D011736:Pyridoxine / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000276:immunology* / Q000628:therapy; D013154:Spleen / Q000276:immunology; D013882:Thiosemicarbazones / Q000627:therapeutic use; D013950:Thymus Gland / Q000276:immunology
D007106:Immune Sera; D013882:Thiosemicarbazones; D015122:Mercaptopurine; D011736:Pyridoxine